Healthcare

enVVeno Medical Corporation (NASDAQ:NVNO) has quietly built one of the more distinctive stories among Nasdaq's small-cap medical-device names. The Irvine, California company is developing replacement valves for diseased veins, a corner of vascular medicine with few approved options, and in 2026 it cleared a …

● Northwest Biotherapeutics is a clinical-stage immuno-oncology company whose lead product candidate, DCVax-L, is a personalized (autologous) dendritic-cell immunotherapy designed to treat glioblastoma multiforme, an aggressive brain cancer.

NewCardio, Inc. (OTC:NWCI) is a reminder that a promising medical-technology story can fade into a dormant ticker within a few short years. Once a Silicon Valley developer of computerised electrocardiogram analysis technology, NewCardio now trades as a sub-penny shell priced at a fraction of …

A recent uptick in Nexalin Technology, Inc. (NASDAQ: NXL) shares came just after a major structural change to the stock. The neurostimulation-device maker completed a reverse stock split at the end of August 2026 to shore up itsNasdaqlisting, and the shares have traded on …

Ocean Biomedical, Inc (OTC:OCEA) is a cautionary example of how quickly a de-SPAC biotech can unravel. The shares now change hands for a fraction of a cent, and the stock's status has shifted dramatically from itsNasdaqdebut.

Few names on the U.S. markets are as quiet as NovelStem International Corp (OTC:NSTM). The stock trades at roughly a penny, itsMarket Valueis measured in the hundreds of thousands of dollars, and its most recent verifiable press releases date back to 2022 and 2023. …

● NeOnc Technologies Holdings fell roughly 11% in a single session, and this time the move traces to a concrete, verifiable event rather than random volatility.